IDXX

IDEXX LABORATORIES INC

Ticker: IDXXMaterialsChemicalsS&P 500
HQ WESTBROOK, MECIK 874716FY end 12-31Book / share $20.22Shares 80M
Revenue (FY)
$4.30B+10.42%
TTM $4.55B
Op. margin
31.60%+2.65%
TTM 32.03%
Net income
$1.06B+19.33%
TTM $1.14B
Operating cash
$1.18B+27.21%
TTM $1.37B
Free cash flow
$1.06B+30.82%
TTM $1.25B
Return on equity
65.99%+10.34%
TTM 70.67%
Debt / equity
0.53-0.02%
TTM 0.60
Shares outstanding
81.0M-2.67%
TTM 79.7M

The business

IDEXX Laboratories, Inc. (NASDAQ: IDEXX) operates as a global developer, manufacturer, and distributor of diagnostic products and services primarily serving the companion animal veterinary, livestock and poultry, water testing, and human medical point-of-care markets. The company's website is www.idexx.com.

The company operates through three primary reportable segments: Companion Animal Group, Water, and Livestock, Poultry and Dairy, along with an Other segment encompassing human medical diagnostics and out-licensing arrangements. The Companion Animal Group represents the largest segment, providing point-of-care diagnostic instruments and consumables, reference laboratory services, veterinary practice management software, diagnostic imaging systems, and telemedicine consultation services to veterinary clinics worldwide. The Water segment offers microbial testing solutions for drinking water, recreational water, and industrial applications. The Livestock, Poultry and Dairy segment supplies diagnostic tests and herd health management products for livestock producers and dairy operations.

IDEXX maintains a global sales and distribution presence across North America, Europe, Asia Pacific, Africa, Canada, and Latin America, operating approximately 80 reference laboratories worldwide. The company employs thousands of professionals across manufacturing facilities in Maine, Georgia, Tennessee, and international locations including the Netherlands, Switzerland, France, and the United Kingdom. Research and development represents a significant investment, with the company dedicating substantial resources to developing innovative diagnostic technologies and software solutions.

The company's product portfolio includes the IDEXX VetLab suite of point-of-care analyzers, SNAP rapid assay test kits, VetConnect PLUS cloud-based diagnostic management software, ezyVet practice management systems, and water testing products such as Colilert and Colisure. IDEXX incorporates artificial intelligence capabilities into several diagnostic platforms and imaging systems to enhance diagnostic accuracy and workflow efficiency.

Founded in 1983 and incorporated in Delaware, IDEXX has established itself through continuous innovation in veterinary diagnostics and complementary software solutions. The company's competitive advantages include its integrated diagnostic platform combining point-of-care instruments, reference laboratory services, and practice management software, along with proprietary AI-enhanced technologies and extensive customer relationships with veterinary practices globally.

Sector
Materials
Industry
Chemicals
HQ
WESTBROOK, ME
FY end
12-31
CIK
874716
SIC
2835
Financial performance · annual
20132025
$-455.32M$910.64M$2.28B$3.64B$5.01B2013201420152016201720182019202020212022202320242025TTMTTMTTM

Ownership

Who holds IDEXX LABORATORIES INC — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30

933
funds hold it
4 of 35
superinvestors hold it
$17.46B
fund-held value
41.1%
of shares held by funds

Top fund holders

Fund% of fundValue
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.06%$1.32B
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.06%$1.08B
VANGUARD MID-CAP INDEX FUND
VO · VANGUARD INDEX FUNDS
0.40%$899.80M
Invesco QQQ Trust, Series 1
QQQ
0.18%$881.50M
Fidelity 500 Index Fund
FXAIX · Fidelity Concord Street Trust
0.07%$575.85M

Superinvestors in IDEXX LABORATORIES INC

Terry SmithDECREASED -30.4%
Fundsmith
3.9%
Polen CapitalDECREASED -23.5%
Polen Capital Management
2.4%
Wallace WeitzUNCHANGED
Weitz Investment Management
1.3%

Share of each manager's reported 13F portfolio.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Go deeper in your own AI

15 years of statements, narrative and filings — queryable over MCP.

Read IDXX's last four 10-Qs: what changed in segment trends, margins and management's narrative?
Run in your AI →

Professionals can also use the built-in AI chat (subscription + your own Anthropic key).

15 years of IDEXX LABORATORIES INC's financials

Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.

Sign in free